PH PRECISION MED

PH Precision Med is a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension.

#More

PH PRECISION MED

Industry:
Biotechnology Health Care

Status:
Active


More informations about "PH Precision Med"

Tenax Therapeutics, Inc. Announces Transformative Acquisition of โ€ฆ

Jan 19, 2021 Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products for the critical care market, โ€ฆSee details»

PH Precision Med 2025 Company Profile: Valuation, Investors ...

Information on acquisition, funding, investors, and executives for PH Precision Med. Use the PitchBook Platform to explore the full profile.See details»

Tenax Buys PH Precision Med, Plans Trial for Oral โ€ฆ

Jan 20, 2021 Tenax Therapeutics has acquired PH Precision Med (PHPM), a private biotech focused on developing imatinib as a treatment for pulmonary โ€ฆSee details»

PH Precision Med - Products, Competitors, Financials, Employees ...

Jan 20, 2021 PH Precision Med (PHPM), a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension (PAH). On โ€ฆSee details»

TENX: Tenax Picks Up PH Precision Med - Yahoo Finance

Jan 20, 2021 By John Vandermosten, CFA NASDAQ:TENX Tenax Acquires PH Precision Med Tenax Therapeutics, Inc. (NASDAQ:TENX) announced yesterday the acquisition of privately โ€ฆSee details»

PH Precision Med - Ownership and Business Overview | Mergr

Jan 19, 2021 Who owns PH Precision Med? PH Precision Med is owned by Tenax Therapeutics. It was acquired on January 19, 2021.See details»

Tenax Therapeutics, Inc. Announces Transformative Acquisition of โ€ฆ

Jan 19, 2021 MORRISVILLE, N.C.-- (BUSINESS WIRE)--Jan 19, 2021-- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, โ€ฆSee details»

Zacks Small Cap Research - TENX: Tenax Picks Up PH Precision Med

Jan 20, 2021 By John Vandermosten NASDAQ:TENX Tenax Acquires PH Precision Med Tenax Therapeutics, Inc. (NASDAQ:TENX) announced yesterday the acquisition of privately held, โ€ฆSee details»

PH Precision Med - Drug pipelines, Patents, Clinical trials - Synapse

Explore PH Precision Med with its drug pipeline, therapeutic area, technology platform, .See details»

Tenax Therapeutics acquires PH Precision Med - Crunchbase

Jan 19, 2021 Overview Acquired Organization: PH Precision Med PHPM is a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary โ€ฆSee details»

Tenax Acquires PH Precision Med | Mergr M&A Deal Summary

On January 19, 2021, Tenax acquired life science company PH Precision Med Acquisition Highlights This is Tenaxโ€™s 1st transaction in the Life Science sector. This is Tenaxโ€™s 1st โ€ฆSee details»

PH Precision Med - Crunchbase

PHPM is a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension.See details»

Precision Health Alliance

The Precision Health Alliance engages thought leaders in healthcare, policy, regulatory practice, and ethics, better understand the future of gene therapy and help develop care pathways for โ€ฆSee details»

Tenax Therapeutics, Inc. Announces Transformative Acquisition of โ€ฆ

Jan 19, 2021 MORRISVILLE, N.C.โ€“ (BUSINESS WIRE)โ€“Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and โ€ฆSee details»

The Promise of Precision Medicine - National Institutes of Health โ€ฆ

Jan 21, 2025 Precision medicine is an innovative approach that takes into account individual differences in patientsโ€™ genes, environments, and lifestyles. Millions of people have already โ€ฆSee details»

Tenax Therapeutics, Inc. Announces Transformative Acquisition of โ€ฆ

Jan 19, 2021 Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing, and commercializing products for the critical care market, today โ€ฆSee details»

Tenax Therapeutics Schedules Conference Call to Discuss Its ...

Jan 20, 2021 On the call, management will review the previously announced acquisition of PH Precision Med (PHPM), a privately-held clinical stage biotech company focused on developing โ€ฆSee details»

PH Precision Med Stock Price, Funding, Valuation, Revenue

See PH Precision Med funding rounds, investors, investments, exits and more. Evaluate their financials based on PH Precision Med's post-money valuation and revenue.See details»

Precision medicine in pulmonary hypertension: how close are we

Although as a scientific field PH remains early in the precision medicine journey, wider availability and lower cost of high throughput -omics platforms, and increasingly sophisticated analytical โ€ฆSee details»

Precision Medicine in Hematologic Malignancies: Evolving ... - MDPI

2 days ago Precision medicine is transforming hematologic cancer care by tailoring treatments to individual patient profiles and moving beyond the traditional โ€œone-size-fits-allโ€ model. This โ€ฆSee details»